Codajás | Tefé | Rio Solimões combined data | |
---|---|---|---|
Venous blood ModPCR prevalence estimates | 49/109 (45 %) | 47/105 (44.8 %) | 96/214 (44.9 %) |
Dried blood spot ModPCR prevalence estimates | 31/105 (29.5 %) | ||
Light microscopy prevalence estimates | 25.7 % (28/109) | 22.9 % (24/105) | 24.3 % (52/214) |
Sub-microscopic infection prevalence estimates | VB-ModPCR: 20.2 % (22/109) | VB-ModPCR: 24.8 %(26/105) | VB-ModPCR: 22.4 % (48/214) |
DBS-ModPCR: 11.4 %(12/105) | DBS or VB ModPCR: 23.8 % (51/214) | ||
DBS or VB ModPCR: 27.6 %(29/105) | |||
Combined data prevalence estimates | VB-ModPCR & LM: 45.9 % (50/109) | VB-ModPCR: 47.6 % (50/105) | VB-ModPCR: 46.7 % (100/214) |
DBS-ModPCR: 34.3 % (36/105) | DBS or VB ModPCR: 48.6 % (104/214) | ||
DBS or VB ModPCR: 51.4 % (54/105) | |||
Light microscopy false negatives | VB-ModPCR & LM: ≥27.2 % (≥22/81) | VB-ModPCR: ≥32.1 % (≥26/81) | VB-ModPCR: 2.08 |
DBS-ModPCR: ≥14.8 % (≥12/81) | DBS-ModPCR: 1.5 | ||
DBS or VB ModPCR:≥35.8 % (≥29/81) | DBS or VB ModPCR: 2.25 | ||
Light microscopy prevalence underestimating | VB-ModPCR & LM: 1.79 × | VB-ModPCR: 2.08 × | VB-ModPCR:1.92 × |
DBS-ModPCR: 1.5 × | DBS or VB ModPCR: 2 × | ||
DBS or VB ModPCR: 2.25 × |